GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (BUE:ABT) » Definitions » Cyclically Adjusted Revenue per Share

Abbott Laboratories (BUE:ABT) Cyclically Adjusted Revenue per Share : ARS5,949.68 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Abbott Laboratories Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Abbott Laboratories's adjusted revenue per share for the three months ended in Mar. 2024 was ARS9,595.817. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ARS5,949.68 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Abbott Laboratories's average Cyclically Adjusted Revenue Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Abbott Laboratories was 11.60% per year. The lowest was -1.70% per year. And the median was 7.90% per year.

As of today (2024-06-07), Abbott Laboratories's current stock price is ARS32072.00. Abbott Laboratories's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ARS5,949.68. Abbott Laboratories's Cyclically Adjusted PS Ratio of today is 5.39.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott Laboratories was 8.42. The lowest was 1.90. And the median was 4.16.


Abbott Laboratories Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Abbott Laboratories's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Cyclically Adjusted Revenue per Share Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 624.92 570.76 911.19 1,706.94 5,182.33

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,087.47 2,679.63 4,366.77 5,182.33 5,949.68

Competitive Comparison of Abbott Laboratories's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Abbott Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Cyclically Adjusted PS Ratio falls into.



Abbott Laboratories Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9595.817/131.7762*131.7762
=9,595.817

Current CPI (Mar. 2024) = 131.7762.

Abbott Laboratories Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 54.169 100.560 70.985
201409 56.271 100.428 73.836
201412 60.179 99.070 80.046
201503 56.996 99.621 75.393
201506 62.461 100.684 81.750
201509 64.341 100.392 84.455
201512 89.736 99.792 118.497
201603 96.167 100.470 126.132
201606 100.715 101.688 130.515
201609 107.140 101.861 138.606
201612 113.940 101.863 147.400
201703 112.571 102.862 144.214
201706 125.144 103.349 159.566
201709 136.439 104.136 172.654
201712 164.910 104.011 208.932
201803 168.700 105.290 211.138
201806 219.010 106.317 271.456
201809 318.041 106.507 393.499
201812 330.102 105.998 410.382
201903 331.586 107.251 407.412
201906 400.236 108.070 488.034
201909 506.296 108.329 615.879
201912 557.880 108.420 678.060
202003 538.642 108.902 651.783
202006 562.088 108.767 680.993
202009 735.235 109.815 882.271
202012 972.818 109.897 1,166.497
202103 1,051.492 111.754 1,239.876
202106 1,080.060 114.631 1,241.599
202109 1,194.567 115.734 1,360.146
202112 1,299.711 117.630 1,456.021
202203 1,439.459 121.301 1,563.766
202206 1,534.503 125.017 1,617.470
202209 1,640.310 125.227 1,726.103
202212 1,930.722 125.222 2,031.780
202303 2,198.438 127.348 2,274.887
202306 2,736.435 128.729 2,801.217
202309 4,060.588 129.860 4,120.521
202312 4,235.362 129.419 4,312.490
202403 9,595.817 131.776 9,595.817

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Abbott Laboratories  (BUE:ABT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Abbott Laboratories's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=32072.00/5949.68
=5.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Abbott Laboratories was 8.42. The lowest was 1.90. And the median was 4.16.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Abbott Laboratories Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (BUE:ABT) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (BUE:ABT) Headlines

From GuruFocus

Q4 2018 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2023 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024